ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1885

Epidemiology of Hospitalized Adult Onset Still’s Disease in United States

Bella Y. Mehta1, William Briggs2 and Petros Efthimiou3, 1Rheumatology, Hospital for Special Surgery/Weill Cornell Medicine/Mailman School of Public Health, New York, NY, 2New York Presbyterian/ Brooklyn Methodist Hospital, New York, NY, 3Medicine/Rheumatology, New York University School of Medicine/NYU Langone Health, New York, NY

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Cost containment, epidemiologic methods and morbidity and mortality, Still's disease

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 6, 2017

Title: Miscellaneous Rheumatic and Inflammatory Diseases I

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: There is a dearth of epidemiological studies on Adult Onset Still’s Disease (AOSD) and no consensus on its incidence and prevalence. Most studies report a majority of patients below the age of 35 [Sakata et al, Rheumatol Int 2016]. Our objective is to describe the demographics, complications and mortality of hospitalized patients with AOSD in USA.

Methods: Adult (>18 years) hospitalized patients between 2009 and 2013 from a nationwide inpatient sample (NIS) database were captured. AOSD patients were identified using the ICD-9 code 714.2 that was in use before 2015. Patients also coded for RA, SLE, Myositis, PMR, AS and Psoriatic Arthritis were excluded. This was done in order to capture patients with strictly AOSD. NIS is the largest all-payer inpatient care database in the United States with approximately 8 million hospitalizations each year. Discharge weights were used to enable nationwide estimates. Descriptive statistics were represented as means/medians for continuous and as frequencies (%) for categorical variables.

Results: Between 2009 and 2013, 5,820 AOSD patients were hospitalized (Table 1). AOSD patients had a mean age of 53.6 (SE – 0.6) years and 3817 (70.4%) were females. The racial/ethnic distribution showed that 56% white, 15% African American, 11.7% Hispanic and 3% Asian patients were affected. 37.6% of patients were hospitalized in urban teaching hospitals. The Mid-Atlantic census division had the highest number of patients (Figure 1). 100 (1.7%) developed Macrophage Activating Syndrome (MAS), 66 (1.1%) patients had disseminated intravascular coagulation (DIC) and 25(0.4%) had thrombotic thrombocytopenic purpura (TTP). The mean length of stay was 6.9 (SE- 0.3) days. There were 154 inpatient deaths in 5 years (mortality 2.6%) (Table 2). The patients who died during hospitalization were more likely to be older, mean age of 62.4 (SE- 3.1) years, women (69.2%) and/or Asian (13.9%).

Conclusion: In hospitalized US AOSD patients, the average age was higher than previously described in cross sectional studies. This may indicate an aging population with a higher number of comorbidities that prompt hospitalization. Mortality increased with age and was higher among women and Asians. To our knowledge, this is the largest epidemiological study of AOSD today in the USA.

 

Table 1: Characteristics of the Hospitalized Adult Onset Still’s Disease over 5 years.

 Year

2009

2010

2011

2012

2013

Total

N

846

995

1,434

1,280

1,265

5,820

Age in Years, Mean (SE)

53.4(1.3)

52.3(1.6)

54.9(1.1)

52.8(1.2)

53.9(1.1)

53.6(0.6)

Female

520 (61.4%)

645 (64.8%)

892 (62.2%)

870 (68%)

890 (70.4%)

3817 (65.6%)

Race

White

437 (51.6%)

515 (51.8%)

819 (57.1%)

760 (59.4%)

730 (57.7%)

3261 (56%)

Black

117 (13.9%)

168 (16.9%)

243 (16.9%)

180 (14.1%)

165 (13%)

874 (15%)

Asian

25 (3%)

47 (4.7%)

29 (2%)

25 (2%)

50 (4%)

175 (3%)

Expected primary payer

Medicare

311 (36.7%)

338 (34%)

589 (41.1%)

525 (41%)

570 (45.1%)

2333 (40.1%)

Medicaid

104 (12.3%)

157 (15.7%)

170 (11.8%)

145 (11.3%)

160 (12.6%)

735 (12.6%)

Private including HMO

351 (41.5%)

373 (37.5%)

474 (33.1%)

475 (37.1%)

375 (29.6%)

2048 (35.2%)

Self-pay

60 (7.1%)

79 (7.9%)

95 (6.6%)

85 (6.6%)

80 (6.3%)

398 (6.8%)

Median household income national quartiles for patient’s ZIP Code

$1 – $38999

205 (24.2%)

276 (27.7%)

294 (20.5%)

340 (26.6%)

315 (24.9%)

1430 (24.6%)

$39000 – $47999

217 (25.7%)

222 (22.3%)

253 (17.6%)

255 (19.9%)

315 (24.9%)

1262 (21.7%)

$48000 – $62999

166 (19.6%)

275 (27.7%)

370 (25.8%)

325 (25.4%)

305 (24.1%)

1442 (24.8%)

$63000+

236 (27.9%)

188 (18.9%)

498 (34.7%)

335 (26.2%)

315 (24.9%)

1572 (27%)

Bed size of the hospital

Small

51 (6%)

78 (7.8%)

123 (8.5%)

175 (13.7%)

140 (11.1%)

566 (9.7%)

Medium

169 (20%)

158 (15.9%)

230 (16.1%)

305 (23.8%)

270 (21.3%)

1133 (19.5%)

Large

341 (40.3%)

384 (38.5%)

462 (32.2%)

640 (50%)

610 (48.2%)

2436 (41.9%)

Location / teaching status of hospital

Rural

60 (7.1%)

93 (9.4%)

88 (6.2%)

65 (5.1%)

100 (7.9%)

406 (7%)

Urban non-teaching

233 (27.6%)

240 (24.2%)

379 (26.4%)

345 (27%)

340 (26.9%)

1538 (26.4%)

Urban teaching

267 (31.6%)

286 (28.8%)

347 (24.2%)

710 (55.5%)

580 (45.8%)

2191 (37.6%)

Transferred in from a different hospital/ facility

71 (8.4%)

72 (7.2%)

138 (9.6%)

130 (10.2%)

125 (9.9%)

535 (9.2%)

In-Hospital death

16 (1.9%)

35 (3.6%)

27 (1.9%)

40 (3.1%)

35 (2.8%)

154 (2.6%)

Length of Stay in days, Mean (SE)

6.1 (0.5)

8.7 (1.1)

7 (0.4)

6.6 (0.4)

6.3 (0.4)

6.9 (0.3)

Cost of hospitalization in USD, Mean (SE)

$ 33,152 (2,406)

$ 25,501 (3,024)

$ 29,633 (2,450)

$ 32,080 (2,590)

$ 31,367 (2,137)

$ 30,857 (516)

*The values are presented as Number (%) unless indicated otherwise

 

Table 2: Description of patients who died in the hospital

N

154

Age in yrs, Mean (SE)

62.4 (3.1)

Age Distribution

18 – 39 yrs

21 (13.4%)

39 – 54 yrs

15 (9.9%)

54 – 67 yrs

50 (32.5%)

67 – 90 yrs

68 (44.3%)

Female

106 (69.2%)

Race

White

81 (52.8%)

Asian

21 (13.9%)

Others

26 (19.8%)

Expected primary payer

Medicare

92 (59.6%)

Medicaid

21 (13.4%)

Private insurance / Self-pay

41 (26.9%)

Median household income – national quartiles for patient’s ZIP Code

$1 – $38,999

15 (9.9%)

$39,000 – $47,999

35 (23.1%)

$48,000 – $62,999

36 (23.5%)

$63,000+

61 (40%)

Bed size of the hospital

Small

16 (10.6%)

Medium

45 (29.5%)

Large

50 (32.7%)

Location/teaching status of hospital

Rural

20 (13.2%)

Urban non-teaching

15 (9.8%)

Urban teaching

77 (49.8%)

Transferred in from a different hospital/ facility

22 (14.6%)

Length of Stay in days, Mean (SE)

13.4(4.4)

Total Charges during hospitalization in USD (SE)

$ 66,083 (18,346)

*The values are presented as Number (%) unless indicated otherwise

 


Disclosure: B. Y. Mehta, None; W. Briggs, None; P. Efthimiou, Abbvie, novartis, BMS, Myriad, medac, janssen,pfizer,mnk, celgene, 5.

To cite this abstract in AMA style:

Mehta BY, Briggs W, Efthimiou P. Epidemiology of Hospitalized Adult Onset Still’s Disease in United States [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/epidemiology-of-hospitalized-adult-onset-stills-disease-in-united-states/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/epidemiology-of-hospitalized-adult-onset-stills-disease-in-united-states/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology